BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 37751047)

  • 1. Senescence, regulators of alternative splicing and effects of trametinib treatment in progeroid syndromes.
    Bramwell LR; Harries LW
    Geroscience; 2024 Apr; 46(2):1861-1879. PubMed ID: 37751047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic alterations in accelerated ageing syndromes. Do they play a role in natural ageing?
    Puzianowska-Kuznicka M; Kuznicki J
    Int J Biochem Cell Biol; 2005 May; 37(5):947-60. PubMed ID: 15743670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p38 (MAPK) stress signalling in replicative senescence in fibroblasts from progeroid and genomic instability syndromes.
    Tivey HS; Brook AJ; Rokicki MJ; Kipling D; Davis T
    Biogerontology; 2013 Feb; 14(1):47-62. PubMed ID: 23112078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Werner and Hutchinson-Gilford progeria syndromes: mechanistic basis of human progeroid diseases.
    Kudlow BA; Kennedy BK; Monnat RJ
    Nat Rev Mol Cell Biol; 2007 May; 8(5):394-404. PubMed ID: 17450177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene expression and DNA repair in progeroid syndromes and human aging.
    Kyng KJ; Bohr VA
    Ageing Res Rev; 2005 Nov; 4(4):579-602. PubMed ID: 16246641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential stem cell aging kinetics in Hutchinson-Gilford progeria syndrome and Werner syndrome.
    Wu Z; Zhang W; Song M; Wang W; Wei G; Li W; Lei J; Huang Y; Sang Y; Chan P; Chen C; Qu J; Suzuki K; Belmonte JCI; Liu GH
    Protein Cell; 2018 Apr; 9(4):333-350. PubMed ID: 29476423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atherosclerosis and Cardiovascular Diseases in Progeroid Syndromes.
    Kato H; Maezawa Y
    J Atheroscler Thromb; 2022 Apr; 29(4):439-447. PubMed ID: 34511576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LMNA mutations in progeroid syndromes.
    Huang S; Kennedy BK; Oshima J
    Novartis Found Symp; 2005; 264():197-202; discussion 202-7, 227-30. PubMed ID: 15773755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of mitochondrial dysfunction in Hutchinson-Gilford progeria syndrome through use of stable isotope labeling with amino acids in cell culture.
    Rivera-Torres J; Acín-Perez R; Cabezas-Sánchez P; Osorio FG; Gonzalez-Gómez C; Megias D; Cámara C; López-Otín C; Enríquez JA; Luque-García JL; Andrés V
    J Proteomics; 2013 Oct; 91():466-77. PubMed ID: 23969228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The human genome project and genomic analysis of progeroid syndromes].
    Nakura J
    Nihon Ronen Igakkai Zasshi; 2002 Jul; 39(4):372-4. PubMed ID: 12187795
    [No Abstract]   [Full Text] [Related]  

  • 11.
    Della Valle F; Reddy P; Yamamoto M; Liu P; Saera-Vila A; Bensaddek D; Zhang H; Prieto Martinez J; Abassi L; Celii M; Ocampo A; Nuñez Delicado E; Mangiavacchi A; Aiese Cigliano R; Rodriguez Esteban C; Horvath S; Izpisua Belmonte JC; Orlando V
    Sci Transl Med; 2022 Aug; 14(657):eabl6057. PubMed ID: 35947677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From old organisms to new molecules: integrative biology and therapeutic targets in accelerated human ageing.
    Cox LS; Faragher RG
    Cell Mol Life Sci; 2007 Oct; 64(19-20):2620-41. PubMed ID: 17660942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. From the rarest to the most common: insights from progeroid syndromes into skin cancer and aging.
    Capell BC; Tlougan BE; Orlow SJ
    J Invest Dermatol; 2009 Oct; 129(10):2340-50. PubMed ID: 19387478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular stress and AMPK activation as a common mechanism of action linking the effects of metformin and diverse compounds that alleviate accelerated aging defects in Hutchinson-Gilford progeria syndrome.
    Finley J
    Med Hypotheses; 2018 Sep; 118():151-162. PubMed ID: 30037605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Progeroid syndromes : Aging, skin aging, and mechanisms of progeroid syndromes].
    Koschitzki K; Ivanova I; Berneburg M
    Dermatologie (Heidelb); 2023 Sep; 74(9):696-706. PubMed ID: 37650893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential expression of metalloproteinase and tissue inhibitor of metalloproteinase genes in aged human fibroblasts.
    Millis AJ; Hoyle M; McCue HM; Martini H
    Exp Cell Res; 1992 Aug; 201(2):373-9. PubMed ID: 1322316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations Involved in Premature-Ageing Syndromes.
    Coppedè F
    Appl Clin Genet; 2021; 14():279-295. PubMed ID: 34103969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Speeding up the clock: The past, present and future of progeria.
    Swahari V; Nakamura A
    Dev Growth Differ; 2016 Jan; 58(1):116-30. PubMed ID: 26691051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mechanism in normal aging and progeroid syndromes].
    Kumahara Y
    Nihon Ronen Igakkai Zasshi; 1988 Jan; 25(1):1-6. PubMed ID: 3385978
    [No Abstract]   [Full Text] [Related]  

  • 20. Prematurely aged children: molecular alterations leading to Hutchinson-Gilford progeria and Werner syndromes.
    Domínguez-Gerpe L; Araújo-Vilar D
    Curr Aging Sci; 2008 Dec; 1(3):202-12. PubMed ID: 20021393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.